Why Moderna Stock Plunged Today
Shares of Moderna (NASDAQ: MRNA) fell 9% on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious new strain of the virus. So what. Investors and the world at large cheered when a phase 3 clinical trial ...
from Google Alert - Business https://ift.tt/37GC66B
Shares of Moderna (NASDAQ: MRNA) fell 9% on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious new strain of the virus. So what. Investors and the world at large cheered when a phase 3 clinical trial ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/37GC66B
Shares of Moderna (NASDAQ: MRNA) fell 9% on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious new strain of the virus. So what. Investors and the world at large cheered when a phase 3 clinical trial ... https://ift.tt/eA8V8J
Comments
Post a Comment